CHATHAM ROCK PHOSPHATE LTD (NZP.CA) Stock Fundamental Analysis

Canada • TSX Venture Exchange • TSX-V:NZP • CA1621631094

0.045 CAD
0 (0%)
Last: Jan 30, 2026, 07:00 PM
Fundamental Rating

1

Taking everything into account, NZP scores 1 out of 10 in our fundamental rating. NZP was compared to 27 industry peers in the Chemicals industry. While NZP seems to be doing ok healthwise, there are quite some concerns on its profitability. NZP has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • NZP had negative earnings in the past year.
  • In the past 5 years NZP always reported negative net income.
  • In the past 5 years NZP always reported negative operating cash flow.
NZP.CA Yearly Net Income VS EBIT VS OCF VS FCFNZP.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 -500K -1M -1.5M -2M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -10.77%, NZP is in line with its industry, outperforming 48.15% of the companies in the same industry.
  • NZP has a Return On Equity (-11.78%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -10.77%
ROE -11.78%
ROIC N/A
ROA(3y)-20.3%
ROA(5y)-16.92%
ROE(3y)-21.69%
ROE(5y)-18.17%
ROIC(3y)N/A
ROIC(5y)N/A
NZP.CA Yearly ROA, ROE, ROICNZP.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -100 -200 -300 -400 -500

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for NZP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NZP.CA Yearly Profit, Operating, Gross MarginsNZP.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -100K -200K -300K -400K

4

2. Health

2.1 Basic Checks

  • NZP has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for NZP has been increased compared to 5 years ago.
  • Compared to 1 year ago, NZP has an improved debt to assets ratio.
NZP.CA Yearly Shares OutstandingNZP.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
NZP.CA Yearly Total Debt VS Total AssetsNZP.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M

2.2 Solvency

  • NZP has an Altman-Z score of -2.80. This is a bad value and indicates that NZP is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -2.80, NZP is doing worse than 66.67% of the companies in the same industry.
  • NZP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -2.8
ROIC/WACCN/A
WACCN/A
NZP.CA Yearly LT Debt VS Equity VS FCFNZP.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2M -2M 4M 6M

2.3 Liquidity

  • NZP has a Current Ratio of 0.22. This is a bad value and indicates that NZP is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.22, NZP is not doing good in the industry: 81.48% of the companies in the same industry are doing better.
  • NZP has a Quick Ratio of 0.22. This is a bad value and indicates that NZP is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.22, NZP is doing worse than 77.78% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.22
Quick Ratio 0.22
NZP.CA Yearly Current Assets VS Current LiabilitesNZP.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500K 1M 1.5M

0

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 46.87% over the past year.
EPS 1Y (TTM)46.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68.57%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NZP.CA Yearly Revenue VS EstimatesNZP.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 1K 2K 3K 4K 5K

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for NZP. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NZP.CA Price Earnings VS Forward Price EarningsNZP.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NZP.CA Per share dataNZP.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 0.04

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • No dividends for NZP!.
Industry RankSector Rank
Dividend Yield 0%

CHATHAM ROCK PHOSPHATE LTD

TSX-V:NZP (1/30/2026, 7:00:00 PM)

0.045

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)09-08
Earnings (Next)03-02
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners13.03%
Ins Owner ChangeN/A
Market Cap5.05M
Revenue(TTM)N/A
Net Income(TTM)-740.10K
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.8
P/tB 0.8
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS0.06
TBVpS0.06
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -10.77%
ROE -11.78%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-20.3%
ROA(5y)-16.92%
ROE(3y)-21.69%
ROE(5y)-18.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.22
Quick Ratio 0.22
Altman-Z -2.8
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)46.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68.57%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y35.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

CHATHAM ROCK PHOSPHATE LTD / NZP.CA FAQ

What is the fundamental rating for NZP stock?

ChartMill assigns a fundamental rating of 1 / 10 to NZP.CA.


What is the valuation status for NZP stock?

ChartMill assigns a valuation rating of 0 / 10 to CHATHAM ROCK PHOSPHATE LTD (NZP.CA). This can be considered as Overvalued.


How profitable is CHATHAM ROCK PHOSPHATE LTD (NZP.CA) stock?

CHATHAM ROCK PHOSPHATE LTD (NZP.CA) has a profitability rating of 1 / 10.